
Funding · 9 September 2026iKure Techsoft Private Limited$1.8MRural healthcare technology and servicesikuretechsoft.com ↗
FundingHealthcare & Life Sciences
iKure raises $1.8 million in Pre-Series A funding
By Abha Lohia · Editor ·
Pre-Series AKolkata
- IKure is a for-profit social enterprise providing primary healthcare, diagnostics, and telemedicine services to rural and semi-urban populations across 11…
- The company secured $1.8 million in a Pre-Series A round from investors including Philips Foundation, World Diabetes Foundation, Bayer Foundation, and…
- The capital will scale clinical infrastructure and enhance the proprietary WHIMS digital platform with new AI-enabled clinical decision support tools
What happened
- The health-tech firm iKure successfully raised $1.8 million in a Pre-Series A funding round.
- Investors participating in the round include Philips Foundation, World Diabetes Foundation, Bayer Foundation, and Japan-based Prourgn LLC.
- The company plans to deploy these funds to expand its network of healthcare hubs, clinics, and pharmacies in underserved regions.
- A significant portion of the investment will upgrade the proprietary WHIMS digital platform with AI-enabled clinical decision support features.
- The funding will also support remote patient monitoring and the development of the company's healthcare workforce.
- This round aims to transition the company from regional coverage toward deeper integration with state and national health systems.
Why it matters
- India faces a significant healthcare gap with over 65% of the population living in rural areas while most doctors remain in cities.
- The national doctor-patient ratio is approximately 1:1,511, which falls below the World Health Organization recommendation of 1:1,000.
- Over 60% of the Indian population currently lacks access to affordable and quality healthcare services.
The business
- iKure operates as a for-profit social enterprise focused on last-mile healthcare delivery.
- The company provides primary healthcare hubs, clinics, pharmacies, and diagnostic services.
- It utilizes a proprietary digital health platform called WHIMS to manage patient data and clinical operations.
- The firm has reached over 36 million people across 7,900 villages in 11 Indian states.
- The network has recorded over 4.5 million patient interactions to date.
- The company employs over 400 trained Community Health Activists to facilitate local care.
- It leverages a network of over 10,000 women-led Self-Help Groups to extend its reach into households.
- The Diabetes360 program provides specialized ongoing care for patients with chronic diabetes.
The founders
SS
Sujay Santra
Founder and CEO- Sujay Santra is the founder and current CEO of iKure.
- He has been invited to speak at major global health forums including PMAC 2025 and India Health 2030.
Who put in money
- Philips Foundation participated — A global foundation focused on improving healthcare access through impact investments.
- World Diabetes Foundation participated — An organization dedicated to preventing and treating diabetes in developing countries.
- Bayer Foundation participated — The philanthropic arm of Bayer, supporting social innovation in health and agriculture.
- Prourgn LLC participated — A Japanese investment firm focused on supporting impactful business models.
In numbers
4.5M+Patient interactions · 2026
7,900Villages reached · 2026
400+Community Health Activists · 2026
What happens next
- Expand the number of healthcare hubs and clinics in underserved regions.
- Integrate AI-enabled clinical decision support into the WHIMS platform.
- Deepen engagement with state and national health planning systems.
Words to know
- Pre-Series A
- An early stage of venture capital funding that occurs after seed funding but before a formal Series A round.
- WHIMS
- The proprietary digital health platform developed by iKure to manage clinical data and patient care.
- Last-mile healthcare
- The final step of the delivery process where healthcare services are provided directly to patients in remote or underserved areas.
- Clinical decision support
- Health information technology systems designed to provide clinicians with knowledge and person-specific information to enhance health and healthcare.
The numbers around it
Healthcare & Life Sciences in September 2026: 11 rounds with a disclosed amount, $114 million in all; the biggest was Ultrahuman ($70 mn). Every sector this year →
Other articles talking about it
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Pre-Series A: A pre-Series A round is money raised after a seed round and before a full Series A, so that a startup can reach the revenue, growth and retention Series A investors expect. In India such rounds commonly run from about ₹5 crore to ₹40 crore, and the label itself is informal.
- Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
All startup news on 9 September 2026 →
Is this iKure Techsoft Private Limited? Get your “Featured on StopDown” badge →